Satyen Madkaiker, MD
Psychiatry · Jacksonville, FLNPI 1588629232
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 399 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$798
- Sunovion Pharmaceuticals Inc.$735
- Takeda Pharmaceuticals U.S.A., Inc.$707
- plus $4K from 23 others
Across 3 payments — averaging $1585.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$5K
What the payments were for
- Food & beverage$9,21999%
- Education$1251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 82 | $1,399 |
| Axsome Therapeutics, Inc. | 41 | $1,084 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $1,046 |
| Otsuka America Pharmaceutical, Inc. | 37 | $798 |
| Sunovion Pharmaceuticals Inc. | 33 | $735 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $707 |
| Alkermes, Inc. | 15 | $435 |
| Vanda Pharmaceuticals Inc. | 13 | $402 |
| Lundbeck LLC | 19 | $370 |
| Idorsia Pharmaceuticals US Inc | 12 | $353 |
| Neurocrine Biosciences, Inc. | 12 | $284 |
| Bausch Health US, LLC | 13 | $246 |
| E.r. Squibb & Sons, L.L.C. | 8 | $240 |
| Johnson & Johnson | 8 | $196 |
| Corium, LLC | 5 | $165 |
| Indivior Inc. | 6 | $164 |
| Avanir Pharmaceuticals, Inc. | 4 | $147 |
| Novo Nordisk | 1 | $121 |
| Tris Pharma Inc | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Ironshore Pharmaceuticals Inc. | 3 | $53 |
| Neos Therapeutics, LP | 3 | $46 |
| Noven Therapeutics, LLC | 2 | $39 |
| Braeburn Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Almatica Pharma LLC | 2 | $31 |
| Orexo US, Inc. | 2 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Exact Sciences | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,344 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 21 | $160,912 |
| VraylarCariprazine Hcl | 89 | $159,688 |
| Invega SustennaPaliperidone Palmitate | 53 | $135,776 |
| Lurasidone Hcl | 303 | $95,444 |
| Abilify MaintenaAripiprazole | 23 | $69,402 |
| TrintellixVortioxetine Hydrobromide | 81 | $63,182 |
| CaplytaLumateperone Tosylate | 34 | $62,289 |
| RexultiBrexpiprazole | 21 | $34,560 |
| AuvelityDextromethorphan Hbr/Bupropion | 13 | $24,327 |
| VyvanseLisdexamfetamine Dimesylate | 50 | $21,801 |
| ClozarilClozapine | 12 | $19,899 |
| Aripiprazole | 241 | $18,471 |
| Ambien CrZolpidem Tartrate | 18 | $15,693 |
| QuviviqDaridorexant Hcl | 29 | $14,560 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $10,908 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $284 | $160,91221 claims |
| AbbVieVraylar | $1,399 | $159,68889 claims |
| Johnson & JohnsonInvega Sustenna | $196 | $135,77653 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $798 | $103,96244 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $707 | $84,983131 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,046 | $62,28934 claims |
| Axsome Therapeutics, Inc.Auvelity | $1,084 | $24,32713 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $353 | $14,56029 claims |
| Indivior Inc.Suboxone | $164 | $10,90820 claims |
| Almatica Pharma LLCSertraline Hcl | $31 | $3,309377 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Jacksonville
- Amit VijapuraJacksonville$112K
- Sagar VijapuraJacksonville$84K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.